The larger risk reductions were not explained by changes in LDL cholesterol, suggesting something else is at play.

Patients with statin resistance do not experience symptoms, Le noted. Instead, the problem is that statins do not lower LDL-C levels as much as they typically do. Instead of a 50% reduction, people ...